These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Olanzapine-induced neuroleptic malignant syndrome with mental retardation. Margolese HC; Chouinard G Am J Psychiatry; 1999 Jul; 156(7):1115-6. PubMed ID: 10401467 [No Abstract] [Full Text] [Related]
48. Risperidone and neuroleptic malignant syndrome. Tarsy D JAMA; 1996 Feb; 275(6):446. PubMed ID: 8627964 [No Abstract] [Full Text] [Related]
49. Case report of neuroleptic malignant syndrome with prolonged mental changes and severe dyskinesia. Chung YJ; Lee SJ Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 29464897 [No Abstract] [Full Text] [Related]
50. [Malignant neuroleptic syndrome associated to risperidone]. Aguirre C; García Monco JC; Mendibil B Med Clin (Barc); 1998 Feb; 110(6):239. PubMed ID: 9547739 [No Abstract] [Full Text] [Related]
51. Risk factors for the neuroleptic malignant syndrome. Kirkpatrick B; Edelsohn GA Psychiatr Med; 1984 Dec; 2(4):371-81. PubMed ID: 6152857 [No Abstract] [Full Text] [Related]
52. Neuroleptic malignant syndrome probably induced by asenapine. Raja S J Neuropsychiatry Clin Neurosci; 2014; 26(4):E36. PubMed ID: 26037883 [No Abstract] [Full Text] [Related]
53. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS. Illing M; Ancill R Can J Psychiatry; 1996 May; 41(4):258. PubMed ID: 8726793 [No Abstract] [Full Text] [Related]
54. A case report of neuroleptic malignant syndrome without fever in a patient given aripiprazole. Rodriguez OP; Dowell MS J Okla State Med Assoc; 2006; 99(7):435-8. PubMed ID: 17017330 [TBL] [Abstract][Full Text] [Related]